Fuentespina, Cecil C.

HRN: 21-50-12  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFUROXIME 1.5GM (VIAL)
06/17/2022
06/17/2022
IVT
1.5g
On Call To OR
For LTCS, Surgical Prophylaxis
Waiting Final Action 
06/17/2022
CEFUROXIME 1.5GM (VIAL)
06/17/2022
06/18/2022
IV
1.5gm
Q8 X 4 Doses
S/p Repeat CS
Waiting Final Action 
06/18/2022
CEFUROXIME 500MG (TAB)
06/18/2022
06/24/2022
ORAL
500mg
BID
Increased Wbc 12.1; S/p RCS With Bilateral Salpingectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: